BAY61-3606 Affects the Viability of Colon Cancer Cells in a Genotype-Directed Manner
Background: K-RAS mutation poses a particularly difficult problem for cancer therapy. Activating mutations in K-RAS are common in cancers of the lung, pancreas, and colon and are associated with poor response to therapy. As such, targeted therapies that abrogate K-RAS-induced oncogenicity would be...
| Autores principales: | , , , , , |
|---|---|
| Otros Autores: | |
| Formato: | Artículo |
| Lenguaje: | en_US |
| Publicado: |
Public Library of Science
2012
|
| Acceso en línea: | http://hdl.handle.net/1721.1/74526 |